amikacin has been researched along with Anemia, Hemolytic, Acquired in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheze, S; De Puyfontaine, O; Leporrier, M; Macro, M; Pan, B; Reman, O; Toudic, F | 1 |
| Citak, A; Garratty, G; Karabocuoglu, M; Ucsel, R; Uzel, N | 1 |
2 other study(ies) available for amikacin and Anemia, Hemolytic, Acquired
| Article | Year |
|---|---|
[Concomitant pulmonary nocardiosis and Hodgkin's disease: importance of long-term treatment].
Topics: Adult; Amikacin; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Erythromycin; Hodgkin Disease; Humans; Imipenem; Long-Term Care; Lung Diseases; Male; Minocycline; Nocardia Infections | 2002 |
Ceftriaxone-induced haemolytic anaemia in a child with no immune deficiency or haematological disease.
Topics: Amikacin; Anemia, Hemolytic; Antigen-Antibody Complex; Ceftriaxone; Cephalosporins; Child, Preschool; Drug Therapy, Combination; Female; Humans; Methylprednisolone; United States; Urinary Tract Infections | 2002 |